Vidyya Medical News Service
*
Volume 5 Issue 108 Published - 14:00 UTC 08:00 EST 18-Apr-2003 Next Update - 14:00 UTC 08:00 EST 19-Apr-2003
little clear gif used for spacer
.
*

FDA announces labeling changes on heart benefit associated with cholesterol drug Zocor
The Food and Drug Administration (FDA) today announced changes to the labeling for Zocor (simvastatin), based on the results of The Heart Protection Study (HPS). The new labeling will reflect research showing that simvastatin is effective in reducing risks of fatal and non-fatal heart attacks, strokes, and in reducing the need for bypass surgery and angioplasty.  more

*
FDA issues guidance on Severe Acute Respiratory Syndrome to further safeguard the blood supply
FDA today issued guidance to the nation's blood establishments on measures for further safeguarding the blood supply against Severe Acute Respiratory Syndrome (SARS). FDA is taking this interim measure to assure the safety of the blood supply while more is learned about the disease. more

 


*
Severe Acute Respiratory Syndrome (SARS) - multi-country outbreak: Situation in China and Hong Kong, status of diagnostic tests
As of April 17 Chinese authorities have reported 12 new cases of SARS. Nine new cases were reported from Guangdong Province, and one each in Inner Mongolia and Sichuan Province. Ningxia, a poor province in the remote western part of the country, announced its first case.  more

*
High blood pressure in pregnancy increases risk of developing cardiovascular disease in later life
Women who have high blood pressure (hypertension) during pregnancy have an increased risk of developing cardiovascular disease in later life, concludes a study in this week's BMJ.  more

*
Researchers find receptor that controls obesity
A cellular receptor that balances the accumulation of fat and fat burning in the body may be a new target for anti-obesity and cholesterol-fighting drugs, according to a Salk Institute study.  more

 
little clear gif used for a space